This paper is in the following e-collection/theme issue:

Immunology, Allergy, Rheumatology (90) Cost-Effectiveness and Economics (252) Substance Abuse (419)

Published on in Vol 11, No 2 (2022): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35300, first published .
Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis

Authors of this article:

Geoff McCombe1 Author Orcid Image ;   Davina Swan1 Author Orcid Image ;   John S Lambert1, 2 Author Orcid Image ;   Eileen O’Connor1 Author Orcid Image ;   Zoe Ward3 Author Orcid Image ;   Peter Vickerman3 Author Orcid Image ;   Gordana Avramovic1, 2 Author Orcid Image ;   Des Crowley4 Author Orcid Image ;   Willard Tinago1 Author Orcid Image ;   Nyashadzaishe Mafirakureva3 Author Orcid Image ;   Walter Cullen1 Author Orcid Image
Article Authors Cited by (2) Tweetations (5) Metrics

Journals

  1. Moulton J, Botfield J, Subasinghe A, Withanage N, Mazza D. Nurse and midwife involvement in task‐sharing and telehealth service delivery models in primary care: A scoping review. Journal of Clinical Nursing 2024;33(8):2971 View
  2. Samartsidis P, Harris R, Dillon J, Desai M, Foster G, Gunson R, Ijaz S, Mandal S, McAuley A, Palmateer N, Presanis A, Simmons R, Smith S, Thorne B, Yeung A, Zaouche M, Hutchinson S, Hickman M, Angelis D. Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK. International Journal of Drug Policy 2024:104429 View